primary overall survival analysis of the zuma-7 trial
Published 1 year ago • 198 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
1:08
zuma-7: overall survival benefit of axi-cel over soc in second-line lbcl
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
2:41
echelon-1 trial updates: overall survival data
-
2:52
zuma-24 preliminary analysis of axi-cel in the outpatient setting in patients with r/r lbcl
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
6:18
orm basics - break even point analysis
-
15:14
survival analysis part3
-
28:56
survival analysis-progression free survival (pfs) - real world evidence. visit: www.swananalytics.in
-
2:09
zuma series update: zuma-1 and zuma-2
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:13
updated overall survival findings from the phase iii intrigue trial
-
8:58
improving the analyses of progression-free survival from clinical trials for novel cancer treatments
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
1:58
transfusion-independence associated with os in simplify-1 and simplfy-2
-
2:55
the discovery of pathogenic germline variants in patients with myeloma
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
3:27
final survival outcomes from the phase iii optimismm trial: pvd versus vd in r/r myeloma